Status:
COMPLETED
Superiority of VCD Versus CTD in Patients With Newly Diagnose Multiple Myeloma Eligible for Transplantation
Lead Sponsor:
Grupo de Estudos Multicentricos em Onco-Hematologia
Conditions:
Multiple Myeloma
Effects of Chemotherapy
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study compared two main different induction protocols used to treat myeloma eligible patients in Brazil. VCD against CTD.
Detailed Description
The primary aim was observe response rate after 4 induction cycles.
Eligibility Criteria
Inclusion
- multiple myeloma newly diagnose elegible to autologous transplantation Patients submitted to ctd or vcd Myeloma patients newly diagnose \>18yo
Exclusion
- other chemotherapy induction protocol
Key Trial Info
Start Date :
June 15 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2017
Estimated Enrollment :
311 Patients enrolled
Trial Details
Trial ID
NCT03402295
Start Date
June 15 2009
End Date
October 15 2017
Last Update
January 18 2018
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.